![]() |
市场调查报告书
商品编码
1401976
2030 年神经电路市场预测:按产品类型、应用、最终用户和地区进行的全球分析Neuronal Circuits Market Forecasts to 2030 - Global Analysis By Product Type (Neurotechnology Devices, Neurodiagnostics, Neurotherapeutics, Electrodes and Probes and Other Product Types), Type, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球神经电路市场规模为 1.947 亿美元,预计到 2030 年将达到 7.017 亿美元,预测期内复合年增长率为 20.1%。
神经刺激设备、神经调节技术和其他用于治疗帕金森氏症、忧郁症和慢性疼痛等疾病的介入措施。成像技术、电极、探针、神经刺激设备和神经技术的进步只是众多可用工具和解决方案的一小部分。理解、修改和利用神经系统中的神经迴路是神经迴路市场的焦点,其中包括相关技术和产品的研究、开发和商业化。
扩大神经科学研究的投资
政府机构、私人投资者和製药公司不断增加的资金正在推动旨在理解和修改神经网路的最尖端科技的创新和创造。这些投资支持探索神经系统疾病、大脑功能的复杂性和潜在治疗方法的研究。此外,更多的资金允许研究人员进行更长时间、更深入的研究,使他们能够开发尖端仪器和设备并发现新的见解。马苏。
缺乏标准化
临床应用和研究中缺乏标准方法、方法论和报告方法抑制了结果的可比较性和再现性。这种多样性使得理解资料和创建检查神经元内神经迴路的标准流程变得困难。不仅机构和研究人员的合作变得更加困难,而且缺乏标准将使研究成果转化为治疗应用变得更加复杂。标准化对于确保资料的真实性和可靠性、促进跨学科合作以及加速可有效整合到医疗程序中的神经技术的开发至关重要。
人口高龄化加剧
随着老年人口数量的增加,阿兹海默症、帕金森氏症和认知能力下降等与老龄化相关的神经系统疾病在国际上呈上升趋势。随着人口老化的增加,迫切需要能够解决老年人复杂神经迴路问题的创新诊断设备、治疗方法和神经刺激设备。此外,这些人口变化凸显了神经科学研究和开发的必要性,以提供适合高龄化社会需求的解决方案。
临床实务中的多种功效
儘管这些治疗方法在治疗神经系统疾病方面显示出前景,但其有效性却存在差异。治疗结果的不可预测性是由于多种因素造成的,包括人类异质性、神经迴路的复杂结构、神经系统疾病的动态性质。这种可变性使得医疗专业人员很难预测和最大化治疗效果。可靠且一致的结果需要深入了解每个大脑迴路的独特特性、个体化的治疗计划以及进一步的研究以改进和标准化技术。
与大流行相关的实验室关闭以及将资源重新分配给与大流行相关的工作,对研究和开发造成了严重干扰。此外,招募患者和使用研究设施方面的困难推迟了针对神经迴路的新神经技术的临床试验。此外,这场流行病提高了人们对心理健康问题的认识,导致人们对神经技术的兴趣和投资增加,以解决忧郁症和焦虑等问题。
神经技术设备产业预计将在预测期内成为最大的产业
由于显着的技术开拓以及对神经迴路在神经功能中发挥的关键作用的日益了解,神经技术设备占据了最大的市场占有率。脑机介面 (BCI)、神经介面、神经刺激设备和矫正器具只是神经技术设备这一大类众多发展成果中的一小部分。此外,这些设备正在引领神经科学研究、治疗和诊断的变革。透过修改特定的神经迴路,深部脑部刺激(DBS)和经颅磁刺激(TMS)等神经刺激设备越来越多地用于治疗神经系统疾病。
预计马达电路领域在预测期内将经历最高的复合年增长率。
由于人们对运动功能复杂性的认识不断提高以及对尖端治疗方法的需求不断增加,运动电路领域有望盈利增长。这种扩散尤其值得注意,因为针对运动迴路的神经技术的发展和使用突显了这些迴路在运动控制和协调中所扮演的关键角色。此外,运动电路部分涵盖了神经假体和脑机介面(BCI)的进展,这些技术直接与运动相关的神经电路连接,并为迷路或瘫痪的人提供运动功能。
亚太地区占据了最大的占有率,因为该地区国家透过对研发的大量投资和医疗基础设施的快速改善而在神经技术创新领域主导地位。对神经系统疾病的了解不断加深,以及影响神经迴路的疾病发生率不断增加,增加了对创新诊断和治疗方法的需求。此外,透过加强学术机构、研究机构和产业贡献者之间的合作努力和伙伴关係,亚太地区正在建立一个充满活力的神经科学研究生态系统。
由于对研究经费、医疗基础设施和合作研究的关注,欧洲地区预计将出现良好的成长。欧洲国家正在大力投资神经迴路研究,从而促进我们对大脑运作方式的理解和最尖端科技的发展。此外,政府对神经科学计画的融资和策略性投资也推动了尖端神经迴路技术的发展,为研究和开发创造了良好的环境。
According to Stratistics MRC, the Global Neuronal Circuits Market is accounted for $194.7 million in 2023 and is expected to reach $701.7 million by 2030 growing at a CAGR of 20.1% during the forecast period. Neurostimulation devices, neuromodulation technologies, and other interventions for the treatment of diseases including Parkinson's disease, depression, and chronic pain. Imaging technologies, electrodes, probes, neurostimulation devices, and neurotechnological advancements are only a few of the many tools and solutions available. Understanding, modifying, and using neuronal circuits in the nervous system is the focus of the market for neuronal circuits, which includes research, development, and commercialization of associated technologies and products.
Growing investments in neuroscience research
Innovation and the creation of cutting-edge technology aimed at understanding and modifying neuronal networks are fueled by increased funding from governmental organizations, private investors, and pharmaceutical corporations. These investments support research exploring neurological conditions, the intricacies of brain function, and potential treatment options. Additionally, more financing enables researchers to execute longer and deeper studies, which results in the development of cutting-edge instruments and gadgets as well as the discovery of novel insights.
Lack of standardization
The lack of standard methods, methodologies, and reporting practices in clinical applications and research inquiries impedes the comparability and reproducibility of results. This diversity makes it difficult to understand the data, which makes it challenging to build standard processes to examine neural circuits in neurons. In addition to making it more difficult for institutions and researchers to collaborate, the lack of standards makes it more complex to convert research findings into therapeutic applications. In order to ensure data authenticity and reliability, promote interdisciplinary collaboration, and accelerate the development of neurotechnologies that may be efficiently integrated into healthcare procedures, standardization is essential.
Growing aging population
Age-related neurological conditions, such as Alzheimer's disease, Parkinson's disease, and cognitive decline, are on the rise internationally in correlation with the growing number of elderly individuals. Innovative diagnostic instruments, treatment approaches, and neurostimulation devices that can address the complexities of older people's neural circuits are desperately needed as the aging population grows. Moreover, this shift in the population emphasizes the need for neuroscience research and development to provide solutions that are specifically customized to the demands of the aging population.
Variable efficacy in clinical settings
Although treating neurological illnesses with these therapies indicates promise, variations in their efficacy may exist. The unpredictable nature of treatment outcomes is attributed to various factors, including human heterogeneity, the complex structure of neural circuits, and the dynamic nature of neurological disorders. The wider use of these technologies is hampered by the variability that presents difficulties for healthcare professionals in anticipating and maximizing the treatment response. Deeper knowledge of the unique properties of each brain circuit, individualized treatment plans, and more research to improve and standardize techniques are necessary for achieving reliable and consistent results.
The pandemic-related closure of laboratories and the reallocation of resources toward pandemic-related efforts caused significant disruptions to research and development. Additionally, difficulties in attracting patients and gaining access to research sites caused delays in clinical trials for new neurotechnologies targeting neuronal circuits. Furthermore, the increased awareness of mental health issues brought on by the pandemic also resulted in increased interest in and investment in neurotechnologies addressing conditions like depression and anxiety.
The neurotechnology devices segment is expected to be the largest during the forecast period
Due to remarkable technological developments and an increasing understanding of the critical role neural circuits play in neurological functioning, neurotechnology devices held the largest market share. Brain-computer interfaces (BCIs), neural interfaces, neurostimulation devices, and neuroprosthetics are just a few instances among the many developments that are included under the broad category of neurotechnology devices. Additionally, these gadgets are leading the way in transforming neuroscience research, therapies, and diagnostics. By modifying particular neural circuits, neurostimulation devices like deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS) are being used more often to treat neurological conditions.
The motor circuits segment is expected to have the highest CAGR during the forecast period
Because of the rising awareness of the complexity of motor function and the increasing demand for cutting-edge therapeutic treatments, the motor circuits segment is expected to grow profitably. The development and use of neurotechnologies that target motor circuits, which emphasize the critical role these circuits play in movement control and coordination, is especially notable for this surge. Furthermore, the Motor Circuits portion covers advancements in neuroprosthetics and brain-computer interfaces (BCIs) that directly interface with motor-related neural circuits, providing motor function for individuals who lose their limbs or are paralyzed.
The Asia Pacific area held the largest share because of the region's countries' leading positions in the field of neurotechnology innovation, which have been established by significant investments in research and development as well as rapid improvements in healthcare infrastructure. The need for innovative diagnostic and treatment approaches has increased due to an increasing understanding of neurological illnesses and the incidence of illnesses affecting neural circuits. Furthermore, a vibrant ecosystem for neuroscience research is being developed in the Asia-Pacific area through a rise in cooperative initiatives and partnerships between academic institutions, research organizations, and industrial contributors.
Because of its heavy emphasis on research funding, healthcare infrastructure, and collaborations, the Europe area is expected to have lucrative growth. European nations have invested heavily in neural circuit research, resulting in advances in the understanding of how the brain works as well as the development of cutting-edge technologies. Furthermore, the growth of cutting-edge neural circuit technology has been fueled by government financing and strategic investments in neuroscience initiatives, which have established a favorable environment for research and development.
Some of the key players in Neuronal Circuits market include BIOPAC Systems, Inc, Blackrock Microsystems, Brain Vision LLC, Cortera Neurotechnologies, Inc, CortiCare, Inc, G.tec medical engineering GmbH, Inscopix, Inc, Neuralink Corporation , Neurologica Corporation, NeuroNexus Technologies, NeuroPace, Inc and Stoelting Co.
In January 2023, NeuroLogica Announces a Research Partnership with the University of Dundee Using State-of-the-Art Photon Counting Detector Technology. The partnership aims to push the boundaries of medical imaging, impact patient outcomes and increase the quality of life for Scottish patients at Dundee.
In November 2022, NeuroLogica Announces FDA 510(k) Clearance of BodyTom 64. The BodyTom 64 was designed to help healthcare professionals bring the power of advanced imaging directly to their patients.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.